These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 12071429)

  • 41. Effects of recombinant human IGF-I on glucose and leucine kinetics in men.
    Elahi D; McAloon-Dyke M; Fukagawa NK; Sclater AL; Wong GA; Shannon RP; Minaker KL; Miles JM; Rubenstein AH; Vandepol CJ
    Am J Physiol; 1993 Dec; 265(6 Pt 1):E831-8. PubMed ID: 8279537
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation of the sensitivity of a new fully implantable telemetry device and the importance of simultaneously measuring cardiac output and left ventricular pressure.
    McKee J; Daller J; Baumgartner B; Pettinger S
    J Pharmacol Toxicol Methods; 2014; 69(3):229-36. PubMed ID: 24468466
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effects of insulin-induced hypoglycaemia on cardiovascular function in normal man: studies using radionuclide ventriculography.
    Fisher BM; Gillen G; Dargie HJ; Inglis GC; Frier BM
    Diabetologia; 1987 Nov; 30(11):841-5. PubMed ID: 3328719
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Absence of hypoglycemia in response to varying doses of recombinant human insulin-like growth factor-I (rhIGF-I) in children and adolescents with low serum concentrations of IGF-I.
    Guevara-Aguirre J; Guevara-Aguirre M; Rosenbloom AL
    Acta Paediatr; 2006 Feb; 95(2):199-202. PubMed ID: 16449027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Evaluation of blood pressure measurement using a miniature blood pressure transmitter with jacketed external telemetry in cynomolgus monkeys.
    McMahon C; Mitchell AZ; Klein JL; Jenkins AC; Sarazan RD
    J Pharmacol Toxicol Methods; 2010; 62(2):127-35. PubMed ID: 20558308
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of recombinant human IGF-I on protein metabolism in post-operative patients without nutrition compared to effects in experimental animals.
    Sandström R; Svanberg E; Hyltander A; Haglind E; Ohlsson C; Zachrisson H; Berglund B; Lindholm E; Brevinge H; Lundholm K
    Eur J Clin Invest; 1995 Oct; 25(10):784-92. PubMed ID: 8557066
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Recombinant human insulin-like growth factor-1 induces an anabolic response in malnourished CAPD patients.
    Fouque D; Peng SC; Shamir E; Kopple JD
    Kidney Int; 2000 Feb; 57(2):646-54. PubMed ID: 10652043
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recombinant human insulin-like growth factor-I therapy improves glycemic control and insulin action in the type A syndrome of severe insulin resistance.
    Morrow LA; O'Brien MB; Moller DE; Flier JS; Moses AC
    J Clin Endocrinol Metab; 1994 Jul; 79(1):205-10. PubMed ID: 8027228
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of a ventral medial hypothalamic lesion on the insulin-induced hypotensive response in normal rats.
    Wright-Richey J; Schultz-Klarr S; Dunbar JC
    Acta Diabetol; 1994 Jun; 31(2):91-7. PubMed ID: 7949229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats.
    Böni-Schnetzler M; Hauri C; Zapf J
    Diabetologia; 1999 Feb; 42(2):160-6. PubMed ID: 10064095
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-like growth factor-1 stimulation of lymphopoiesis.
    Clark R; Strasser J; McCabe S; Robbins K; Jardieu P
    J Clin Invest; 1993 Aug; 92(2):540-8. PubMed ID: 8349796
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term effect of recombinant human insulin-like growth factor I on metabolic and growth control in a patient with leprechaunism.
    Nakae J; Kato M; Murashita M; Shinohara N; Tajima T; Fujieda K
    J Clin Endocrinol Metab; 1998 Feb; 83(2):542-9. PubMed ID: 9467572
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Recovery of growth hormone release from suppression by exogenous insulin-like growth factor I (IGF-I): evidence for a suppressive action of free rather than bound IGF-I.
    Chapman IM; Hartman ML; Pieper KS; Skiles EH; Pezzoli SS; Hintz RL; Thorner MO
    J Clin Endocrinol Metab; 1998 Aug; 83(8):2836-42. PubMed ID: 9709956
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Modification by propranolol of cardiovascular effects of induced hypoglycaemia.
    Lloyd-Mostyn RH; Oram S
    Lancet; 1975 May; 1(7918):1213-5. PubMed ID: 48835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes].
    Kato M
    Hokkaido Igaku Zasshi; 1998 Nov; 73(6):613-25. PubMed ID: 10036618
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of vagal cooling on the counterregulatory response to hypoglycemia induced by a low dose of insulin in the conscious dog.
    Cardin S; Jackson PA; Edgerton DS; Neal DW; Coffey CS; Cherrington AD
    Diabetes; 2001 Mar; 50(3):558-64. PubMed ID: 11246875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cardiac Autonomic Regulation and Repolarization During Acute Experimental Hypoglycemia in Type 2 Diabetes.
    Chow E; Bernjak A; Walkinshaw E; Lubina-Solomon A; Freeman J; Macdonald IA; Sheridan PJ; Heller SR
    Diabetes; 2017 May; 66(5):1322-1333. PubMed ID: 28137792
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the metabolic effects of recombinant human insulin-like growth factor-I and insulin. Dose-response relationships in healthy young and middle-aged adults.
    Boulware SD; Tamborlane WV; Rennert NJ; Gesundheit N; Sherwin RS
    J Clin Invest; 1994 Mar; 93(3):1131-9. PubMed ID: 8132753
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of vagal blockade on the counterregulatory response to insulin-induced hypoglycemia in the dog.
    Jackson PA; Pagliassotti MJ; Shiota M; Neal DW; Cardin S; Cherrington AD
    Am J Physiol; 1997 Dec; 273(6):E1178-88. PubMed ID: 9435534
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Short- and long-term metabolic effects of recombinant human IGF-I treatment in patients with severe insulin resistance and diabetes mellitus.
    Vestergaard H; Rossen M; Urhammer SA; Müller J; Pedersen O
    Eur J Endocrinol; 1997 May; 136(5):475-82. PubMed ID: 9186267
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.